The Australian arm of a Brisbane-based biotech company that struck a $300 million deal to send COVID-19 home testing kits to the US has gone into voluntary administration.
A meeting of Ellume's creditors is to be held later this month. Ellume's US business is not affected.
Ellume rose to prominence last year when it signed an agreement with the US Department of Defense to provide COVID home test kits.
